LOGAN SYSTEM 914-12 Automated Dry-Heated 12-Position Transdermal Diffusion System

Overview

The LOGAN SYSTEM 914-12 is a fully automated, dry-heated, 12-position transdermal diffusion system engineered for high-throughput, regulatory-compliant permeation and release testing of topical and semi-solid pharmaceutical formulations. It operates on the principle of Franz-type diffusion cell methodology—employing static or dynamic receptor chamber configurations with precise temperature control, consistent donor application, and programmable sampling intervals. Unlike water-jacketed systems, the SYSTEM 914-12 utilizes proprietary dry-heating technology to deliver rapid, uniform thermal equilibration across all 12 diffusion cells (±0.2 °C stability), eliminating condensation risks, reducing maintenance overhead, and enhancing long-term operational reliability in GLP- and GMP-regulated environments.

Key Features

• Modular architecture comprising two DHC-6T dry-heated diffusion cell units, one SCR-DL sample collector, one SYP-12L-10 mL precision syringe pump, and one DSC-800 central system controller—enabling synchronized, independent operation of up to 12 diffusion cells
• Integrated automatic bubble removal function at the donor–membrane interface, minimizing air entrapment artifacts that compromise mass transfer kinetics and assay reproducibility
• High-accuracy syringe pump (±1% volumetric accuracy, 0.1–10 mL/min flow range) supporting programmable sampling volumes (e.g., 0.2–2.0 mL) with minimal dead volume and carryover
• Dry-heating design achieves <3 min thermal stabilization from ambient to 32 °C; eliminates water bath contamination, evaporation drift, and mechanical failure associated with circulating fluid systems
• Ergonomic diffusion cell assembly with snap-fit silicone gaskets and low-profile clamping mechanism—reducing cell breakage risk during repeated disassembly and enabling rapid cleaning between runs
• Real-time monitoring of acceptor medium temperature via individual Pt100 sensors embedded in each receptor chamber, logged at user-defined intervals (e.g., every 30 s)
• FDA 21 CFR Part 11-compliant data audit trail: time-stamped event logging (e.g., pump activation, temperature deviation, user login/logout), electronic signatures, and immutable record retention
• Three-tier user permission structure (Administrator, Supervisor, Analyst) with role-based access control for method editing, data export, and system configuration

Sample Compatibility & Compliance

The SYSTEM 914-12 supports standardized vertical diffusion cell formats per USP and Ph. Eur. 2.9.17, accommodating membranes including human epidermis, excised porcine skin, Strat-M®, and synthetic lipid bilayers. It is validated for use with diverse formulation types: ointments, gels, creams, emulsions, patches, lotions, sunscreens, and cosmetic serums. All wetted components are chemically inert (316 stainless steel, PTFE, borosilicate glass, medical-grade silicone), ensuring compatibility with organic solvents (e.g., ethanol, isopropanol, propylene glycol) and surfactant-containing matrices. The system meets ISO/IEC 17025 calibration traceability requirements and supports IQ/OQ/PQ documentation packages aligned with ICH Q5C and ASTM E2372 standards.

Software & Data Management

Control and data acquisition are managed via LOGAN’s proprietary WinTransderm v5.x software (Windows 10/11 compatible), featuring intuitive graphical workflow builder, real-time concentration curve visualization, and automated calculation of key pharmacokinetic parameters—including cumulative permeation (μg/cm²), flux (μg/cm²/h), lag time (h), and permeability coefficient (cm/h). Raw sensor data, method files, and audit logs are stored in encrypted SQLite databases with optional network backup. Export options include CSV, PDF reports (with digital signature), and XML for LIMS integration. Electronic records comply with ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) and support inspection readiness for FDA, EMA, and PMDA audits.

Applications

• Regulatory submission studies for ANDA, NDA, and MAA dossiers requiring in vitro release testing (IVRT) and in vitro permeation testing (IVPT)
• Formulation optimization: evaluating impact of excipients, pH, viscosity, and penetration enhancers on drug flux and membrane residence time
• Stability-indicating method development for quantifying active ingredient depletion or degradation product formation in receptor media
• Comparative bioequivalence assessment of generic transdermal products against reference listed drugs (RLDs)
• Cosmetic efficacy screening: quantifying penetration depth and retention of actives (e.g., niacinamide, retinol, peptides) in ex vivo skin models
• Method validation per ICH Q2(R2): linearity, accuracy, precision (intra-day/inter-day), LOD/LOQ, and robustness testing under deliberate parameter variation (e.g., ±1 °C temp, ±5% pump speed)

FAQ

Is the SYSTEM 914-12 compliant with USP and Ph. Eur. 2.9.17?
Yes—the diffusion cell geometry, membrane area (1.77 cm² standard), receptor volume (5.0 mL), and agitation specifications meet both compendial requirements.
Can the system accommodate non-standard membrane sizes or custom cell geometries?
Yes—optional adapter kits support 0.64 cm² and 3.14 cm² diffusion areas; custom-machined cells can be integrated upon engineering review.
Does the DSC-800 controller support remote monitoring via Ethernet or Wi-Fi?
Yes—Ethernet connectivity enables secure remote access through authenticated VNC or browser-based dashboard (HTTPS/TLS 1.2); Wi-Fi requires external industrial-grade bridge.
What validation documentation is provided with shipment?
Each system ships with Factory Acceptance Test (FAT) report, Certificate of Conformance, NIST-traceable temperature calibration certificate, and IQ/OQ protocol templates.
Is online solvent degassing supported as a factory-installed option?
Yes—the optional SOL-DEG module integrates inline vacuum degassing (≤5 kPa absolute pressure) upstream of the syringe pump, reducing nucleation-induced sampling error in volatile solvent systems.